Anna R Hemnes1, Alexander R Opotowsky2, Tufik R Assad1, Meng Xu3, Laura N Doss4, Eric Farber-Eger5, Quinn S Wells5, Evan L Brittain6. 1. Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN. 2. Department of Medicine, Brigham and Women's Hospital, Boston, MA and Department of Cardiology, Boston Children's Hospital, Boston, MA. 3. Department of Biostatistics, Vanderbilt University, Nashville, TN. 4. Duke Triangle Heart Associates, Durham, NC. 5. Division of Cardiovascular Medicine and Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center, Nashville, TN. 6. Division of Cardiovascular Medicine and Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center, Nashville, TN. Electronic address: evan.brittain@vumc.org.
Abstract
BACKGROUND: The measurements used to define pulmonary hypertension (PH) etiology, pulmonary arterial wedge pressure (PAWP), and left ventricular end-diastolic pressure (LVEDP) vary in clinical practice. We aimed to identify clinical features associated with measurement discrepancy between PAWP and LVEDP in patients with PH. METHODS: We extracted clinical data and invasive hemodynamics from consecutive patients undergoing concurrent right and left heart catheterization at Vanderbilt University between 1998 and 2014. The primary outcome was discordance between PAWP and LVEDP in patients with PH in a logistic regression model. RESULTS: We identified 2,270 study subjects (median age, 63 years; 53% men). The mean difference between PAWP and LVEDP was -1.6 mm Hg (interquartile range, -15 to 12 mm Hg). The two measurements were moderately correlated by linear regression (R = 0.6, P < .001). Results were similar when restricted to patients with PH. Among patients with PH (n = 1,331), older age (OR, 1.77; 95% CI, 1.23-2.45) was associated with PAWP underestimation in multivariate models, whereas atrial fibrillation (OR, 1.75; 95% CI, 1.08-2.84), a history of rheumatic valve disease (OR, 2.2; 95% CI, 1.36-3.52), and larger left atrial diameter (OR, 1.70; 95% CI, 1.24-2.32) were associated with PAWP overestimation of LVEDP. Results were similar in sensitivity analyses. CONCLUSIONS: Clinically meaningful disagreement between PAWP and LVEDP is common. Atrial fibrillation, rheumatic valve disease, and larger left atrial diameter are associated with misclassification of PH etiology when relying on PAWP alone. These findings are important because of the fundamental differences in the treatment of precapillary and postcapillary PH.
BACKGROUND: The measurements used to define pulmonary hypertension (PH) etiology, pulmonary arterial wedge pressure (PAWP), and left ventricular end-diastolic pressure (LVEDP) vary in clinical practice. We aimed to identify clinical features associated with measurement discrepancy between PAWP and LVEDP in patients with PH. METHODS: We extracted clinical data and invasive hemodynamics from consecutive patients undergoing concurrent right and left heart catheterization at Vanderbilt University between 1998 and 2014. The primary outcome was discordance between PAWP and LVEDP in patients with PH in a logistic regression model. RESULTS: We identified 2,270 study subjects (median age, 63 years; 53% men). The mean difference between PAWP and LVEDP was -1.6 mm Hg (interquartile range, -15 to 12 mm Hg). The two measurements were moderately correlated by linear regression (R = 0.6, P < .001). Results were similar when restricted to patients with PH. Among patients with PH (n = 1,331), older age (OR, 1.77; 95% CI, 1.23-2.45) was associated with PAWP underestimation in multivariate models, whereas atrial fibrillation (OR, 1.75; 95% CI, 1.08-2.84), a history of rheumatic valve disease (OR, 2.2; 95% CI, 1.36-3.52), and larger left atrial diameter (OR, 1.70; 95% CI, 1.24-2.32) were associated with PAWP overestimation of LVEDP. Results were similar in sensitivity analyses. CONCLUSIONS: Clinically meaningful disagreement between PAWP and LVEDP is common. Atrial fibrillation, rheumatic valve disease, and larger left atrial diameter are associated with misclassification of PH etiology when relying on PAWP alone. These findings are important because of the fundamental differences in the treatment of precapillary and postcapillary PH.
Authors: Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch Journal: J Am Coll Cardiol Date: 2013-12-24 Impact factor: 24.094
Authors: David M Kaye; Frank E Silvestry; Finn Gustafsson; John G Cleland; Dirk J van Veldhuisen; Piotr Ponikowski; Jan Komtebedde; Shane Nanayakkara; Dan Burkhoff; Sanjiv J Shah Journal: Eur J Heart Fail Date: 2017-10-11 Impact factor: 15.534
Authors: Julia Mascherbauer; Caroline Zotter-Tufaro; Franz Duca; Christina Binder; Matthias Koschutnik; Andreas A Kammerlander; Stefan Aschauer; Diana Bonderman Journal: JACC Heart Fail Date: 2017-10-11 Impact factor: 12.035
Authors: Tufik R Assad; Evan L Brittain; Quinn S Wells; Eric H Farber-Eger; Stephen J Halliday; Laura N Doss; Meng Xu; Li Wang; Frank E Harrell; Chang Yu; Ivan M Robbins; John H Newman; Anna R Hemnes Journal: Pulm Circ Date: 2016-09 Impact factor: 3.017
Authors: Omri Gottesman; Helena Kuivaniemi; Gerard Tromp; W Andrew Faucett; Rongling Li; Teri A Manolio; Saskia C Sanderson; Joseph Kannry; Randi Zinberg; Melissa A Basford; Murray Brilliant; David J Carey; Rex L Chisholm; Christopher G Chute; John J Connolly; David Crosslin; Joshua C Denny; Carlos J Gallego; Jonathan L Haines; Hakon Hakonarson; John Harley; Gail P Jarvik; Isaac Kohane; Iftikhar J Kullo; Eric B Larson; Catherine McCarty; Marylyn D Ritchie; Dan M Roden; Maureen E Smith; Erwin P Böttinger; Marc S Williams Journal: Genet Med Date: 2013-06-06 Impact factor: 8.822
Authors: Tufik R Assad; Bradley A Maron; Ivan M Robbins; Meng Xu; Shi Huang; Frank E Harrell; Eric H Farber-Eger; Quinn S Wells; Gaurav Choudhary; Anna R Hemnes; Evan L Brittain Journal: JAMA Cardiol Date: 2017-12-01 Impact factor: 14.676
Authors: Elke Boxhammer; Moritz Mirna; Laura Bäz; Brunilda Alushi; Marcus Franz; Daniel Kretzschmar; Uta C Hoppe; Alexander Lauten; Michael Lichtenauer Journal: J Clin Med Date: 2022-05-25 Impact factor: 4.964
Authors: Andriy O Samokhin; Steven Hsu; Paul B Yu; Aaron B Waxman; George A Alba; Bradley M Wertheim; C Danielle Hopkins; Frederick Bowman; Richard N Channick; Ivana Nikolic; Mariana Faria-Urbina; Paul M Hassoun; Jane A Leopold; Ryan J Tedford; Corey E Ventetuolo; Peter J Leary; Bradley A Maron Journal: J Heart Lung Transplant Date: 2019-12-31 Impact factor: 10.247
Authors: Micha T Maeder; Lukas Weber; Sebastian Seidl; Daniel Weilenmann; David Hochholzer; Lucas Joerg; Joannis Chronis; Johannes Rigger; Philipp K Haager; Hans Rickli Journal: CJC Open Date: 2021-07-10
Authors: Elke Boxhammer; Sarah X Gharibeh; Bernhard Wernly; Malte Kelm; Marcus Franz; Daniel Kretzschmar; Uta C Hoppe; Alexander Lauten; Michael Lichtenauer Journal: J Cardiovasc Dev Dis Date: 2022-09-04
Authors: Vineet Agrawal; Michele D'Alto; Robert Naeije; Emanuele Romeo; Meng Xu; Tufik R Assad; Ivan M Robbins; John H Newman; Meredith E Pugh; Anna R Hemnes; Evan L Brittain Journal: J Am Heart Assoc Date: 2019-08-31 Impact factor: 5.501